Proactive COVID-19 testing
By identifying COVID-19 positive cases early on, particularly those that are asymtomatic, we can restrict further transmission of this deadly virus.
How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective
Syngene’s 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies. As a result, the typical time from clinical candidate to regulatory filing is just 11 months.
Your one-stop-shop for Biologics
Syngene helps biopharma companies accelerate large molecule therapies to market through integrated biologics CDMO services, with manufacturing facilities across the U.S. and India. With a GMP capacity of 50 KL in single-use bioreactors, featuring 500 L, 2000 L and 4000 L units designed to deliver economies of scale, Syngene offers innovative, flexible, and efficient solutions […]
Dedicated R&D Centres – The Next Step In The Pharma Outsourcing Model
Syngene’s Dedicated R&D Centre is a unique business model where we set up a dedicated ring-fenced infrastructure with an exclusive team of scientific talent to support client projects.
Syngene’s Supply Chain Management Improves Efficiency
Syngene’s SCM team manages more than 1,000 vendors and 20,000 item codes in the SAP ERP system, enabling easy access and order placement.
Syngene Viral Testing Facility – Striving for Excellence
Syngene, is India’s first and only GLP-certified service provider for Viral Clearance and Safety Testing. Our laboratories are per the OECD rules covering countries such as USA and Japan.